×
NexGel Operating Expenses 2021-2024 | NXGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NexGel operating expenses from 2021 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
NexGel Operating Expenses 2021-2024 | NXGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NexGel operating expenses from 2021 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$194.7B
Intuitive Surgical (ISRG)
$191.9B
Alcon (ALC)
$42.1B
Edwards Lifesciences (EW)
$41.4B
IQVIA Holdings (IQV)
$34.7B
IDEXX Laboratories (IDXX)
$34.1B
DexCom (DXCM)
$29.2B
STERIS (STE)
$20.9B
Waters (WAT)
$20.5B
SONOVA HOLDING (SONVY)
$20.3B
Hologic (HOLX)
$18.2B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.7B
Globus Medical (GMED)
$11.3B
Penumbra (PEN)
$9.1B
Teleflex (TFX)
$9B
Masimo (MASI)
$8.8B
Glaukos (GKOS)
$8B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.5B
Veracyte (VCYT)
$3B
Inari Medical (NARI)
$3B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.8B
Nihon Kohden (NHNKY)
$2.3B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$1.8B
RxSight (RXST)
$1.8B
Integra LifeSciences Holdings (IART)
$1.8B
Alphatec Holdings (ATEC)
$1.4B